All too often, medical treatments revolve around a ‘trial and error’ approach. This wastes NHS time, resources and could even potentially harm patients.
However, if doctors could diagnose through simple yet efficient gene testing kits, then this could transform the diagnosing process. Mark Street-Docherty is pictured – image courtesy of Elucigene Diagnostics. “For us, it was very much about answering an unserviced area of the genetics market.” Mark Street-Docherty, CEO at Elucigene Diagnostics, tells…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
